CSL has been Australia's national fractionator of plasma-derived therapies since 1952.For further information visit the Australian Red Cross Blood Service website.Today, Australian Governments continue to choose CSL Behring as Australia's national plasma fractionator, and we are regulated by the Therapeutic Goods Administration, a regulator held in high regard worldwide.Working together CSL Behring in Australia and the Australian Red Cross Blood Service ensure that the blood and plasma donations made voluntarily by Australia's community continue to deliver the benefits that self-sufficiency provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiencies, a range of haematological and neurological disorders, haemophilia, haemolytic disease of the newborn and trauma.Source: this is an extract from the company's own website
CSL has been Australia's national fractionator of plasma-derived therapies since 1952.For further information visit the Australian Red Cross Blood Service website.Today, Australian Governments continue to choose CSL Behring as Australia's national plasma fractionator, and we are regulated by the Therapeutic Goods Administration, a regulator held in high regard worldwide.Working together CSL Behring in Australia and the Australian Red Cross Blood Service ensure that the blood and plasma donations made voluntarily by Australia's community continue to deliver the benefits that self-sufficiency provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiencies, a range of haematological and neurological disorders, haemophilia, haemolytic disease of the newborn and trauma.Source: this is an extract from the company's own website
CSL has been Australia's national fractionator of plasma-derived therapies since 1952.For further information visit the Australian Red Cross Blood Service website.Today, Australian Governments continue to choose CSL Behring as Australia's national plasma fractionator, and we are regulated by the Therapeutic Goods Administration, a regulator held in high regard worldwide.Working together CSL Behring in Australia and the Australian Red Cross Blood Service ensure that the blood and plasma donations made voluntarily by Australia's community continue to deliver the benefits that self-sufficiency provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiencies, a range of haematological and neurological disorders, haemophilia, haemolytic disease of the newborn and trauma.Source: this is an extract from the company's own website